Abstract
During the past two decades, a number of variable genetic sequences have been uncovered that permit molecular typing of Mycobacterium tuberculosis complex (MTC) organisms. Since the determination of the M. tuberculosis, and later M. bovis, genome sequences, the nature of these variable genetic sequences has become more evident, permitting a clearer recognition of which molecular tools lend themselves best to certain applications. In this review, ‘classical’ genotyping methods for molecular epidemiologic uses are briefly discussed, followed by a more detailed description of post-genomic typing methods, including large sequence polymorphisms otherwise referred to as genomic deletions. Because genomic deletions represent unique event polymorphisms not prone to reversion, these mutations effectively ‘brand’ bacterial lineages, including species/subspecies of the MTC and specific clades of M. tuberculosis sensu stricto. Genomic deletions therefore provide a new opportunity to accurately classify organisms for diagnostic and epidemiologic purposes, serving as the basis for further study of the natural variability across MTC organisms.
Keywords: Molecular typing, DNA sequence polymorphisms, genomic deletions
Current Molecular Medicine
Title: Molecular Tools for Typing and Branding the Tubercle Bacillus
Volume: 7 Issue: 3
Author(s): Marcel A. Behr and Serge Mostowy
Affiliation:
Keywords: Molecular typing, DNA sequence polymorphisms, genomic deletions
Abstract: During the past two decades, a number of variable genetic sequences have been uncovered that permit molecular typing of Mycobacterium tuberculosis complex (MTC) organisms. Since the determination of the M. tuberculosis, and later M. bovis, genome sequences, the nature of these variable genetic sequences has become more evident, permitting a clearer recognition of which molecular tools lend themselves best to certain applications. In this review, ‘classical’ genotyping methods for molecular epidemiologic uses are briefly discussed, followed by a more detailed description of post-genomic typing methods, including large sequence polymorphisms otherwise referred to as genomic deletions. Because genomic deletions represent unique event polymorphisms not prone to reversion, these mutations effectively ‘brand’ bacterial lineages, including species/subspecies of the MTC and specific clades of M. tuberculosis sensu stricto. Genomic deletions therefore provide a new opportunity to accurately classify organisms for diagnostic and epidemiologic purposes, serving as the basis for further study of the natural variability across MTC organisms.
Export Options
About this article
Cite this article as:
Behr A. Marcel and Mostowy Serge, Molecular Tools for Typing and Branding the Tubercle Bacillus, Current Molecular Medicine 2007; 7 (3) . https://dx.doi.org/10.2174/156652407780598593
DOI https://dx.doi.org/10.2174/156652407780598593 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Use of Nitric Oxide Synthase Inhibitors in Inflammatory Diseases: A Novel Class of Anti-Inflammatory Agents
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Antibiotic Sensitivity of Bacillus clausii Strains in Commercial Preparation
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) New Approved Medications for Idiopathic Pulmonary Fibrosis
Current Drug Therapy The Last Decade of Carbon Paste Electrodes in DNA Electrochemistry
Current Analytical Chemistry Protein Tagging, Destruction and Infection
Current Protein & Peptide Science The Chemical Composition and Anti-mycobacterial Activities of <i>Trachyspermum copticum</i> and <i>Pelargonium graveolens</i> Essential Oils
Recent Patents on Anti-Infective Drug Discovery Bioluminescent Quantitation and Detection of Gene Expression During Infectious Disease
Combinatorial Chemistry & High Throughput Screening Phytoconstituents of <i>Lantana camara</i> L.: Rekindling Hope in the Cancer Treatment
Current Bioactive Compounds Radiolabelled Peptides and Monoclonal Antibodies for Therapy Decision Making in Inflammatory Diseases
Current Pharmaceutical Design Anticonvulsant and Antitubercular Activities of 6-Phenyl/Biphenyl-4-yl-2- [2-(pyridin-2-ylamino)-ethyl]- and 6-(Biphenyl-4yl)-2-(2N-subtituted amin- 1-yl)-ethyl derivatives of 4,5-dihydropyridazin-3(2H)-one
Letters in Drug Design & Discovery Antimicrobial Precious-Metal Nanoparticles and their Use in Novel Materials
Recent Patents on Food, Nutrition & Agriculture Synthesis of 1H-1,2,3-triazoles and Study of their Antifungal and Cytotoxicity Activities
Medicinal Chemistry Computer-aided Identification of Novel DprE1 Inhibitors as Potential Anti-TB Lead Compounds: A Hybrid Virtual-screening and Molecular Dynamics Approach
Letters in Drug Design & Discovery Nebulizer Therapy in Pulmonology: Review of the Literature
Current Respiratory Medicine Reviews Impact of Cerebral Malaria on Brain Distribution of Mefloquine
Drug Metabolism Letters An 8-Year Retrospective Study of Human Visceral Leishmaniasis
Current Clinical Pharmacology Neuropeptides as Therapeutic Approach to Autoimmune Diseases
Current Pharmaceutical Design Role of Fas-Ligand Induced Apoptosis in Pulmonary Inflammation and Injury
Current Drug Targets - Inflammation & Allergy Mitochondria-Mediated Oxidative Stress: Old Target for New Drugs
Current Medicinal Chemistry Management of Tuberculosis in Children and New Treatment Options
Infectious Disorders - Drug Targets